Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin
(Q77787475)
scientific article published on 01 January 1999
scientific article published on 01 January 1999
Language:
Current Data About
Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin